Psychosis Clinical Trials in Montreal, Quebec
7 recruitingMontreal, Quebec, Canada
Showing 1–7 of 7 trials
Recruiting
Phase 3
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company500 enrolled154 locationsNCT06126224
Recruiting
Phase 3
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company800 enrolled416 locationsNCT05980949
Recruiting
Phase 3
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Alzheimer DiseasePsychosis
Bristol-Myers Squibb325 enrolled20 locationsNCT06947941
Recruiting
Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories
Depression - Major Depressive DisorderADHDPsychosis+4 more
Douglas Mental Health University Institute560 enrolled1 locationNCT06978452
Recruiting
HYEEG Discourse in Psychosis: A Neurobehavioural Study
Schizophrenia DisordersPsychosis
Douglas Mental Health University Institute110 enrolled1 locationNCT06978803
Recruiting
Predicting Psychotic Relapse Using Speech-Based Early Detection
Psychosis
Douglas Mental Health University Institute250 enrolled3 locationsNCT06978894
Recruiting
Not Applicable
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
Cognitive DysfunctionPsychotic DisordersCannabis Use+5 more
Douglas Mental Health University Institute134 enrolled1 locationNCT05445180